BlackRock’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120M | Sell |
|
|||||
|
2025
Q1 | $139M | Sell |
|
|||||
|
2024
Q4 | $127M | Buy |
|
|||||
|
2024
Q3 | $84M | Buy |
|
|||||
|
2024
Q2 | $80.2M | Buy |
|
|||||
|
2024
Q1 | $66M | Buy |
|
|||||
|
2023
Q4 | $19.1M | Buy |
|
|||||
|
2023
Q3 | $21.3M | Sell |
|
|||||
|
2023
Q2 | $40.3M | Sell |
|
|||||
|
2023
Q1 | $50.6M | Sell |
|
|||||
|
2022
Q4 | $77.2M | Buy |
|
|||||
|
2022
Q3 | $97.1M | Buy |
|
|||||
|
2022
Q2 | $97.6M | Buy |
|
|||||
|
2022
Q1 | $83.1M | Buy |
|
|||||
|
2021
Q4 | $89.5M | Buy |
|
|||||
|
2021
Q3 | $100M | Sell |
|
|||||
|
2021
Q2 | $116M | Buy |
|
|||||
|
2021
Q1 | $122M | Buy |
|
|||||
|
2020
Q4 | $81.4M | Buy |
|
|||||
|
2020
Q3 | $60.3M | Buy |
|
|||||
|
2020
Q2 | $47.4M | Buy |
|
|||||
|
2020
Q1 | $25.8M | Buy |
|